| Document |
Document Title |
|
JP2002527500A |
The invention concerns intermediates of formula or wherein R 5 is alkyl or alkenyl of one to ten carbons. Preferably, R 5 is isobutyl.
|
|
JP2002523529A |
Disclosed are compositions from which radically initiated oligomers/polymers having a controlled molecular weight, low polydispersity and a vinyl or dienyl end group are prepared. Further subjects of the invention are a process for contr...
|
|
JP2002522415A |
The invention relates to a compound of formula Ia, Ib or IcThe open chain alkoxyamine compounds are useful for the polymerization of ethylenically unsaturated monomers. The compounds of the present invention provide polymeric resin produ...
|
|
JP2002167366A |
To efficiently produce a cationic surface active agent of good tone.The cationic surface active agent is produced by reacting alkanolamine ester to form a quaternary compound under the solvent-free condition, in the presence of 10-50 ppm...
|
|
JP2002155104A |
To provide a method for increasing the molar mass of an cationic acryloyloxyethyltrimethylammonium chloride copolymer so that the copolymer may display improved efficacies (such as an improved flocculant function and an improved paper fi...
|
|
JP2002145834A |
To provide a new monomer solving the problem on insufficient cationicity depending on applications, to provide a method for producing the monomer, and to provide a homopolymer or copolymer having the unit derived from the monomer.This ne...
|
|
JP2002514618A |
The invention relates to quaternary ester compounds which have an ethoxylated hydroxycarboxylic acid as their basic framework. These cationic tensides are suitable for the production of water-white formulations, such as in particular hai...
|
|
JP3282799B2 |
To obtain a new compound useful as a medicine for treating and/or preventing dysuria, convulsion or hyperanakinesia in human or animal. This compound is represented by formula I [R1 is an aryl (substituted with a halogen, OH or the like)...
|
|
JP2002514190A |
Briefly, in one aspect, the present invention provides compositions of open-chain, alpha -branched fluoroalkylcarbonyl fluorides, and derivatives thereof.
|
|
JP2002512639A |
The application relates to the use of a beta 3 adrenergic receptor agonist selected from the group consisting of formulas (IV),(V),(VI),(VII) and (VIII) for the manufacture of a medicament for the prophylactic and/or the therapeutic trea...
|
|
JP3271052B2 |
To obtain a new compound useful as a photo-polymerization initiator for ethylene unsaturated compound and a photo-reaction initiator for the photo- setting of a pigment system as a printing ink or a white lacquer. This compound is expres...
|
|
JP3268825B2 |
PURPOSE: To obtain alkyl 3-chloroanthranilates in a high rate compared with other undesirable isomers directly from the corresponding alkyl anthanilates. CONSTITUTION: Alkyl esters of anthranilic acid expressed by formula I (R is 1 to 4C...
|
|
JP2002508776A |
The present invention provides optically pure (S) 2-methylamino-2-phenyl-n-butyl 3,4,5-trimethoxybenzoate for use in the treatment of chronic pain, and having Formula (I). The present invention also provides methods of using the compound...
|
|
JP2002507590A |
The invention concerns anti-tumour agents of formula (I) wherein each of R1, R2 and R3 has the meanings defined in the specification including hydrogen, (1-4C)alkyl, (3-4)alkenyl, (3-4C)alkynyl, amino, (1-4C)alkylamino and (1-4C)alkoxy; ...
|
|
JP2002069182A |
To provide a new multi-functional diamine which is a useful monomer having organic groups containing carbon-carbon double bond or carbon-carbon triple bond providing photo-reactivity together with thermal reactivity specific to these rea...
|
|
JP3256502B2 |
To screening the subject compound by providing the compound to the first and second cell types, measuring the influence thereof on the receptor activities, and selecting the compound providing the influence only to the first cell type. T...
|
|
JP2002037786A |
To provide a method for synthesizing (S)-4-{[3-[2-(dimethylamino) ethyl]-1H-indol-5-yl]methyl}-2-oxazolidinone by an improved process.This method for synthesizing the oxazolidinone compound includes the following processes: (a) a process...
|
|
JP2002500235A |
The present invention relates to quaternary ammonium compounds and formulations thereof useful as cleaning compositions, antistatic compounds, fabric softeners, hair conditioners, skin conditioners, paper deinking and ink floatation, age...
|
|
JP2001527052A |
The present invention relates to new polyamide oligomers. These oligomers can be conjugated to lipids, nucleic acids, peptides, proteins, etc. The oligomer-lipid conjugates can be used to form liposomes, virusomes, micelles, etc., option...
|
|
JP2001526300A |
[Chemical 1] An effective amount of at least one compound indicated by is added to the fuel. R in the equation1, R2And R3The groups are independent of each other, alkyl or hydroxyalkyl groups containing 1 to 4 carbon atoms, aryl or alkyl...
|
|
JP2001525349A |
The invention relates to the utilization of detergent mixtures containing (a) ester quaternaries which can be obtained by the condensation of fatty acids with alkanolamines and subsequent quaternization of the alkanolamine oligo-ester, a...
|
|
JP3236022B2 |
PCT No. PCT/EP92/01924 Sec. 371 Date Feb. 18, 1994 Sec. 102(e) Date Feb. 18, 1994 PCT Filed Aug. 21, 1992 PCT Pub. No. WO93/04148 PCT Pub. Date Mar. 4, 1993.A novel compound comprises a chemical compound comprising or including a cyclic ...
|
|
JP2001524965A |
(57) [Summary] The fabric softener compound is of the formula: [RC (O)]nN+(R1)mX-In the above formula, each R in the compound preferably has an IV of about 70 to about 140 based on the IV of the corresponding fatty acid, C.6-C22It is a h...
|
|
JP3234228B2 |
Heterocyclic compounds of formula (I) and their acid addition salts are new. A = (A1) -O-CO-; (A2) -CH2O-CO; (A3) -O-CH2-CO-; (A4) -O-CH2-CH2-; (A5) -N(R1)-CO-; (A6) -N(R1)-CO-CO-; (A7) -N(R1)-CH2-CH2-; or (A8) -O-CH2-; R1 = H or 1-4C al...
|
|
JP3231775B2 |
Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene and their use in therapeutic field are described. The compounds are particularly useful in the treatment of arterial hypertension, cardiac decompensation and renal failure, in the trea...
|
|
JP3231172B2 |
PURPOSE: To obtain the amine acid salt having a homogeneous neutralization value and a stability in storage for a long period of time, by contacting and mixing a specific di-long ohain type tertiary amine with an acid in a specific mixin...
|
|
JP2001519846A |
A composition mixture having the following general formula (I) below R1R2R3N wherein R1 is a group having the formula R6-(O-CHR5-CH2)a-OCHR4-CH2-; or CnH(2n+1-x)(OR8)x; in which R4 is H or C1-C4 alkyl; R5 is independently, in each occurr...
|
|
JP2001278846A |
To provide a method for producing a powdery quaternary ammonium salt in high yield. The powdery quaternary ammonium salt can be produced in high yield by reacting a tertiary amine represented by general formula (I) or (II) with a quatern...
|
|
JP2001253915A |
To provide a new fluoroalkyl group-containing trialkylammonium oligomer having both an excellent functionality of a fluorine compound and an excellent functionality of an ammonium salt, to provide a method of producing the same, and to p...
|
|
JP3210019B2 |
The present invention discloses cationic lipids useful for making lipid aggregates for delivery of macromolecules and other compounds into cells. They are especially useful for the DNA-dependent transformation of cells. Also disclosed ar...
|
|
JP2001514221A5 |
|
|
JP3207901B2 |
An intermediate of the formula: and an intermediate of the formula: or an acid addition salt thereof.M
|
|
JP2001226334A |
To provide a method for stabilizing unsaturated quaternary ammonium salts, capable of preventing their deterioration such as coloring or polymerization in their production, transportation or storage and increasing their stability without...
|
|
JP2001220356A |
To provide the design, development, composition and use of a new calcimimetic molecule capable of acting on extracellular calcium ion on the cell by a method mimicking the calcium ion, a calcilytic inhibiting the activity of the intercel...
|
|
JP2001213830A |
To provide a new difluorocyclopropane derivative where various constituents are combined with two carbon atoms except fluorine atom-combined carbon atom in a difluorocyclopropane ring.This difluorocyclopropane derivative is represented b...
|
|
JP2001510481A |
The present invention provides intermediate for the preparation of indane-like compounds which are useful for the modulation of a muscarinic receptor.
|
|
JP3193052B2 |
Tissue paper webs useful in the manufacture of soft, absorbent products such as napkins, facial tissues, and sanitary tissues, and processes for making the webs. The tissue paper webs comprise papermaking fibers, a biodegradable quaterni...
|
|
JP2001187763A |
To provide a method for producing a (meth)acrylic ester by transesterification reaction by which the precipitation of a solid is hardly caused even if the temperature is lowered, and the formation of byproducts is little. This method for...
|
|
JP3182720B2 |
To obtain a mew α-aminoacetophenone derivative bearing allyl or aralkyl group on the α-site, having especially high activity as a photoinitiator, and effectively usable in esp. printing inks. This new derivative is a compound (acid-add...
|
|
JP2001172236A |
To provide a purification method obtaining the objective dimethylaminoethyl acrylate by distilling off methyl acrylate and dimethylaminoethanol by continuous distillation from a mixed solution containing at least methyl acrylate, dimethy...
|
|
JP3167208B2 |
PURPOSE: To preserve an amino compound bearing ester group without coloration by adding a specific color phase stabilizer to the compound and replacing the atmosphere in the system with an inert gas. CONSTITUTION: ON As color phase stabi...
|
|
JP3167210B2 |
PURPOSE: To obtain a new compound, excellent in flexibility and biodegradability and suitable as a soft base, etc., for hair treating agents, etc., without stickiness in drying. CONSTITUTION: This compound is expressed by formula I {R1 a...
|
|
JP2001131171A |
To provide a pharmaceutical composition containing a new compound capable of acting as a neurokinin receptor antagonist as an active ingredient. This pharmaceutical composition contains a compound expressed by the following formula (1) a...
|
|
JP3164426B2 |
PURPOSE: To provide a new compound useful for electrophotographic photoreceptor having high sensitivity and durability. CONSTITUTION: The compound of formula I [R1 is H or methyl; R2 to R5 are (substituted)alkyl, alkoxy, (substituted)ary...
|
|
JP2001504808A |
N-(4-(Etherified or esterified hydroxy)-phenyl)-amide compounds of formula (I) are new. Y1-Y4 = H, halo, alkyl, haloalkyl, alkoxy, haloalkoxy, alkylthio or haloalkylthio; R1 =alkyl, alkenyl, aryl, cycloalkyl, cycloalkenyl or heterocyclyl...
|
|
JP2001504531A |
The invention relates to polymers with antimicrobial properties, consisting of: a) 99-40 wt % non functional vinylically polymerizable monomers and b) 1-60 wt % functional vinylically polymerizable monomers of general formula (I) wherein...
|
|
JP3142583B2 |
|
|
JP2001501586A |
A process is disclosed for making a solid composition comprising at least one quaternary ester ammonium compound and at least one substantially saturated fatty acid compound, a solid composition obtainable by that process, and a solid co...
|
|
JP3126183B2 |
There are described new 2-cyclohexan-1-yl-amine derivatives of formula (I) (I) in which A, R1, R2, R3 and R4 have the meaning given in the description, and processes for their preparation. The compounds of the formula (I) are used as ant...
|
|
JP2001500473A |
Ester quats of the formula (1) below are described: where RCO is an aliphatic acyl radical having 6 to 22 carbon atoms, R1 is a methyl radical, R2 is a C1-C6-alkyl radical, R3 is a C3-C6-alkyl radical and X- is a halogen anion. They are ...
|
